COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,885 Articles (22,568 medRxiv, 8,317 bioRxiv)

Most recent first Previous |  Page 2063: Articles 20621-20630  | Next

Risk factors for outcomes of COVID-19 patients: an observational study of 795 572 patients in Russia
Demkina, A. E., Morozov, S., Vladzymyrskyy, A. V., Kljashtorny, V. G., Guseva, O. I., Pugachev, P. S., Artemova, O. R., Reshetnikov, R. V., Gombolevskiy, V. A., Ryabinina, M. N.
10.1101/2020.11.02.20224253 — Posted: 2020-11-04
Emergence of Novel SARS-CoV-2 Variants in the Netherlands
Urhan, A., Abeel, T.
10.1101/2020.11.02.20224352 — Posted: 2020-11-04
High attack rates of SARS-CoV-2 infection through household-transmission: a prospective study
Kuwelker, K., Zhou, F., Blomberg, B., Lartey, S., Brokstad, K. A., Trieu, M. C., Madsen, A., Krammer, F., Mohn, K. G. I., Toendel, C., Linchausen, D. W., Cox, R. J., Langeland, N.
10.1101/2020.11.02.20224485 — Posted: 2020-11-04 Discussion: Onsite
Cohorting of Non-Critically Ill COVID-19 Patients: A Multicenter Survey Study (COVID-COHORT)
Purohit, U., Fralick, M.
10.1101/2020.11.01.20194233 — Posted: 2020-11-04
Understanding COVID-19 testing pathways in English care homes to identify the role of point-of-care testing: an interview-based process mapping study
Micocci, M., Gordon, A., Allen, J., Hicks, T., Kierkegaard, P., McLister, A., Walne, S., Buckle, P.
10.1101/2020.11.02.20224550 — Posted: 2020-11-04
Effectiveness of quarantine and testing to prevent COVID-19 transmission from arriving travelers
Russell, W. A., Buckeridge, D. L.
10.1101/2020.11.02.20224568 — Posted: 2020-11-04
Simulation model for productivity, risk and GDP impact forecasting of the COVID-19 portfolio vaccines
Shnaydman, V.
10.1101/2020.11.01.20214122 — Posted: 2020-11-04
Are Mobile Phones part of the chain of transmission of SARS-CoV-2 in the hospital?
Sanchez Espinoza, E. P., Farrel Cortes, M., Vasconez Nogueira, S., Vincente de Paula, A., Guimaraes, T., Santos Vilas Boas, L., Park, M., Carvalho da Silva, C., Morales, I., Vieira Perdigao Neto, L., Tozetto-Mendoza, T. R., Boszczowski, I., Sabino, E., Mendes-Correa, M. C., Shafferman Levin, A. S., Figueiredo Costa, S.
10.1101/2020.11.02.20224519 — Posted: 2020-11-04
CSF of SARS-CoV-2 patients with neurological syndromes reveals hints to understand pathophysiology
Bernard-Valnet, R., Perriot, S., Canales, M., Pizzarotti, B., Caranzano, L., Castro-Jimenez, M., Epiney, J.-B., Vijiala, S., Salvioni Chiabotti, P., Anichini, A., Salerno, A., Jaton, K., Vaucher, J., Perreau, M., Greub, G., Pantaleo, G., Du Pasquier, R.
10.1101/2020.11.01.20217497 — Posted: 2020-11-04
Modelling the impact of COVID-19-related control programme interruptions on progress towards the WHO 2030 target for soil-transmitted helminths
Malizia, V., Giardina, F., Vegvari, C., Bajaj, S., McRae-McKee, K., Anderson, R. M., De Vlas, S. J., Coffeng, L. E.
10.1101/2020.11.01.20220376 — Posted: 2020-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).